Inhibition of microRNA-122 alleviates pyroptosis by targeting dual-specificity phosphatase 4 in myocardial ischemia/reperfusion injury
2023 · Heliyon · 7 citations
https://doi.org/10.1016/j.heliyon.2023.e18238
Q
Qiang Fu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
36
Papers
112
Citations
4
h-index
3
i10-index
Qiang Fu is an academic researcher from Shandong Provincial Hospital. The author has contributed to research in topics: Urological Disorders and Treatments & Pelvic floor disorders treatments & Prostate Cancer Treatment and Research. The author has an h-index of 4, co-authored 31 publications.
ORCID: 0000-0002-4409-1237Papers by this author
worksAdditional file 2 of Network meta-analysis on the effects of finerenone versus SGLT2 inhibitors and GLP-1 receptor agonists on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus and chronic kidney disease
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.21510376
Additional file 1 of Network meta-analysis on the effects of finerenone versus SGLT2 inhibitors and GLP-1 receptor agonists on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus and chronic kidney disease
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.21510373
41P Surufatinib plus toripalimab and chemotherapy for second-line treatment of RAS/BRAF mutant (MT) microsatellite stable (MSS) metastatic colorectal cancer (mCRC): A single-arm, phase II study (APHRODITE)
2024 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2024.05.052
Shenlian Decoction Ameliorates LPS‐Related Inflammation in db/db Mice: Coupling Network Pharmacology With Experimental Verification
2025 · Journal of Diabetes Research · 0 citations
https://doi.org/10.1155/jdr/3823051
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat